{"version":"1.0","type":"link","title":"Multicenter Randomized Double-Blind Phase III Trial of Donafenib in Progressive Radioactive Iodine-Refractory Differentiated Thyroid Cancer.","author_name":"Lin Y 외","author_url":"https://prs-insight.online/author/Lin%20Y","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/145455","thumbnail_width":1200,"thumbnail_height":630}